Caladrius Bio (CLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLBS | AMGN | VRTX | REGN | GSK |
| Company | Caladrius Bio | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 9.7200 | 315.28 | 442.00 | 969.27 | 44.85 |
| High | 9.7500 | 315.28 | 446.10 | 982.77 | 45.09 |
| Low | 5.7300 | 310.37 | 440.35 | 966.00 | 44.74 |
| Last | 6.3960 | 312.47 | 445.21 | 982.29 | 44.98 |
| Change | -1.2585 | -2.25 | +4.57 | +14.31 | +0.10 |
| % Change | -16.44% | -0.71% | +1.04% | +1.48% | +0.22% |
| Volume | 1,796,440 | 1,974,200 | 1,382,400 | 386,500 | 1,882,900 |
| 20-Day Average Volume | 1,469,975 | 2,910,960 | 1,122,380 | 455,815 | 3,491,155 |
| Previous Close | 7.6545 | 314.72 | 440.64 | 967.98 | 44.88 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5057 | 293.57 | 412.42 | 939.27 | 43.25 |
| 20-Day Raw Stochastic | 16.57% | 82.19% | 98.36% | 94.14% | 84.16% |
| 20-Day Relative Strength | 32.97% | 63.74% | 72.10% | 61.09% | 66.00% |
| Weighted Alpha | -64.50 | +38.84 | +33.13 | +30.85 | +31.55 |
| Today's Opinion | 88% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 72% Sell | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.39% since 09/07/22 | +0.75% since 05/10/24 | +5.31% since 05/10/24 | +0.87% since 05/10/24 | -0.20% since 05/10/24 |
| Low | 0.3820 on 09/14/22 | 307.06 on 05/13/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.74 on 05/17/24 |
| High | 0.6500 on 09/14/22 | 321.44 on 05/15/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | -20.63% since 08/12/22 | +18.33% since 04/17/24 | +13.26% since 04/17/24 | +9.00% since 04/17/24 | +13.59% since 04/17/24 |
| Low | 0.3820 on 09/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 0.6500 on 09/14/22 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -14.72% since 06/14/22 | +10.14% since 02/16/24 | +5.45% since 02/16/24 | +3.61% since 02/16/24 | +7.25% since 02/16/24 |
| Low | 0.3820 on 09/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 0.6500 on 09/14/22 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -34.40% since 03/14/22 | +17.74% since 11/17/23 | +27.02% since 11/17/23 | +22.41% since 11/17/23 | +27.78% since 11/17/23 |
| Low | 0.3820 on 09/14/22 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 34.97 on 11/20/23 |
| High | 0.7960 on 03/24/22 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 25,833 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 60,583 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -27,470,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -6,630,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.91 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/04/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 11/03/22 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 11.11 |